<?xml version="1.0"?>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title>In-house HIV-1 RNA real-time RT-PCR assays : principle, available tests and usefulness in developing countries</dc:title>
  <dc:creator>Rouet, F.</dc:creator>
  <dc:creator>M&#xE9;nan, H.</dc:creator>
  <dc:creator>Viljoen, J.</dc:creator>
  <dc:creator>/Ngo-Giang-Huong, Nicole</dc:creator>
  <dc:creator>Mandaliya, K.</dc:creator>
  <dc:creator>Val&#xE9;a, D.</dc:creator>
  <dc:creator>Lien, T. X.</dc:creator>
  <dc:creator>Danaviah, S.</dc:creator>
  <dc:creator>Rousset, D.</dc:creator>
  <dc:creator>Ganon, A.</dc:creator>
  <dc:creator>Nerrienet, E.</dc:creator>
  <dc:subject>Developing country</dc:subject>
  <dc:subject>Genetic diversity</dc:subject>
  <dc:subject>Hiv-1</dc:subject>
  <dc:subject>Pcr</dc:subject>
  <dc:subject>Quantitative</dc:subject>
  <dc:subject>Real-time</dc:subject>
  <dc:subject>Reverse transcription</dc:subject>
  <dc:subject>Rna</dc:subject>
  <dc:subject>Viral load</dc:subject>
  <dc:description>The principle of currently available licensed HIV-1 RNA assays is based on real-time technologies that continuously monitor the fluorescence emitted by the amplification products. Besides these assays, in-house quantitative (q) real-time reverse transcription (RT)-PCR (RT-qPCR) tests have been developed and evaluated particularly in developing countries, for two main reasons. First, affordable and generalized access to HIV-1 RNA viral load is urgently needed in the context of expected universal access to prevention and antiretroviral treatment programs in these settings. Second, since many non-B subtypes, circulating recombinant forms and unique recombinant forms circulate in these areas, in-house HIV-1 RNA RT-qPCR assays are ideal academic tools to thoroughly evaluate the impact of HIV-1 genetic diversity on the accuracy of HIV-1 RNA quantification, as compared with licensed techniques. To date, at least 15 distinct in-house assays have been designed. They differ by their chemistry and the HIV-1 target sequence (located in gag, Pol-IN or LTR gene). Analytical performances of the tests that have been extensively evaluated appear at least as good as (or even better than) those of approved assays, with regard to HIV-1 strain diversity. Their clinical usefulness has been clearly demonstrated for early diagnosis of pediatric HIV-1 infection and monitoring of highly active antiretroviral therapy efficacy. The LTR-based HIV-1 RNA RT-qPCR assay has been evaluated by several groups under the auspices of the Agence Nationale de Recherches sur le SIDA et les hepatites virales B et C. It exists now as a complete standardized commercial test.</dc:description>
  <dc:date>2008</dc:date>
  <dc:type>text</dc:type>
  <dc:identifier>https://www.documentation.ird.fr/hor/fdi:010083650</dc:identifier>
  <dc:identifier>fdi:010083650</dc:identifier>
  <dc:identifier>Rouet F., M&#xE9;nan H., Viljoen J., Ngo-Giang-Huong Nicole, Mandaliya K., Val&#xE9;a D., Lien T. X., Danaviah S., Rousset D., Ganon A., Nerrienet E.. In-house HIV-1 RNA real-time RT-PCR assays : principle, available tests and usefulness in developing countries. 2008, 8 (5),  635-650</dc:identifier>
  <dc:language>EN</dc:language>
</oai_dc:dc>
